Human umbilical cord is a unique and safe source of various types of stem cells suitable for treatment of hematological diseases and for regenerative medicine

Blood Cells, Molecules, and Diseases

Volumn 49, Issue 1, 2012, Pages 20-28

  Pelosi, Elvira ^a   Castelli, Germana ^a   Testa, Ugo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cord blood; Endothelial cells; Hematopoietic stem cells; Mesenchymal stem cells; Placenta; Transplantation

Indexed keywords

ANGIOPOIETIN; CHEMOKINE RECEPTOR CXCR4; FLT3 LIGAND; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR; THROMBOPOIETIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ALLOTRANSPLANTATION; CARTILAGE CELL; CD34 SELECTION; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; COLONY FORMING UNIT; CRYOPRESERVATION; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HEMANGIOBLAST; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGENICITY; MESENCHYMAL STEM CELL; NEUTROPHIL; NONHUMAN; OSTEOBLAST; PHENOTYPE; PLACENTA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOCYTE; UMBILICAL CORD; UNRESTRICTED SOMATIC STEM CELL; VERY SMALL EMBRYONIC EPIBLAST LIKE STEM CELL; WHARTON JELLY;

FETAL BLOOD; HEMATOLOGIC DISEASES; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS; UMBILICAL CORD; WHARTON JELLY;

EID: 84861337181     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.02.007     Document Type: Review

References (118)

1. Knudtzon S. In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 1974, 43:357-361.
2. Beuzard Y., Vainchenker W., Testa U., et al. Fetal to adult hemoglobin switching in cultures of early erythroid precursors from human fetuses and neonates. Am. J. Hematol. 1979, 7:207-218.
3. Broxmeyer H.E., Douglas G.W. Human umbilical cord blood as a potential source of transplantable hematopoietic/stem progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:3828-3832.
4. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 1989, 321:1174-1178.
5. Gluckman E., Ruggeri A., Volt F., Cunha R., Boudjedir K., Rocha V. Milestones in umbilical cord blood transplantation. Br. J. Haematol. 2011, 154:441-447.
6. Sullivan M.J. Banking on cord blood stem cells. Nat. Rev. Cancer 2008, 8:555-563.
7. Brunstein C.G. Umbilical cord blood transplantation for the treatment of hematologic malignancies. Cancer Control 2011, 18:222-236.
8. H. Riu, E. Rich, L. Godley, et al., Reduced intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD and durable remissions, Blood 118 (2011) 6438-6445.
9. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
10. + cord blood cells transplanted into NOD/SCID mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:413-418.
11. Ishikawa F., Yasukawa M., Lyons B., et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor (gamma) chain (null) mice. Blood 2005, 106:1565-1573.
12. Majeti R., Park C.Y., Weissman I.L. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 2007, 1:635-645.
13. Kikushige Y., Yoshimoto G., Miyamoto T., et al. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. J. Immunol. 2008, 180:7358-7367.
14. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat. Immunol. 2010, 11:585-593.
15. Notta F., Doulatov S., Laurenti E., Poeppl A., Jurisca I., Dick J. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011, 333:218-221.
16. Critser P.J., Voytik-Harbin S.L., Yoder M.C. Isolating and defining cells to engineer human blood vessels. Cell Prolif. 2011, 44(Suppl. 1):15-21.
17. Yoder M., Mead L., Prater D., Krier T., Mrough K., Li F. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principles. Blood 2007, 109:1801-1809.
18. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
19. Baker C.D., Ryan S.L., Ingram D.A., Seedorf G.J., Abman S.H., Balasubramaniam V. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am. J. Respir. Crit. Care Med. 2009, 180:454-461.
20. Reimisch A., Hoffmann N.A., Obenauf A., et al. Humanized-large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 2009, 113:6716-6725.
21. Au P., Daheron L.M., Duda D.G., et al. Differential in vivo potential of endothelial progenitor of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood and adult peripheral blood to form functional long-lasting vessels. Blood 2008, 111:1302-1305.
22. + cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 2007, 35:1109-1118.
23. Estes M.L., Mund J.A., Mead L.E., et al. Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry 2010, 77:831-839.
24. Lavergne M., Vanneaux V., Delmon C., Gluckman E., Rodda-Astier I., Laghero J., Uzan G. Cord blood-circulating endothelial progenitors for treatment of vascular diseases. Cell Prolif. 2011, 44:44-47.
25. J.P. Zape, A.C. Zovein, Hemogenic endothelium: origins, regulation, and implications for vascular biology, Semin. Cell Dev. Biol. 22 (2011) 1036-1047.
26. Pelosi E., Valtieri M., Coppola S., et al. Identification of the hemangioblast in postnatal life. Blood 2002, 100:3203-3208.
27. Wu X., Lensch W., Wylie-Sears J., Daley G., Bischoff J. Hemogenic endothelial progenitor cells isolated from human umbilical cord blood. Stem Cells 2007, 25:2770-2776.
28. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103:1669-1675.
29. Flynn A., Barry F., O'Brien T. UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 2007, 9:717-726.
30. Secco M., Zucconi E., Vieira N.M., et al. Multipotent stem cells from umbilical cord: cord is richer than blood!. Stem Cells 2008, 26:146-150.
31. Oh W., Kim D.S., Yang Y.S., Lee J.K. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell. Immunol. 2008, 251:116-123.
32. Wang M., Yang Y., Yang D., Luo F., Liang W., Guo S., Xu J. The immunomodulatory actrivity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 2009, 126:220-232.
33. Kim J.Y., Leon H.B., Yang Y.S., Oh W., Chang J.W. Application of umbilical cord blood-derived mesenchymal stem cells in disease models. World J. Stem Cells 2010, 26:34-38.
34. Majore I., Moretti P., Stahla F., Hass R., Kasper C. Growth and differentiation properties of mesenchymal stromal populations derived from whole human cord blood. Stem Cell. Rev. Rep. 2011, 7:17-31.
35. Karahuseyinoglu S., Cinar O., Kilic E., et al. Biology of stem cells in human cord blood stroma: in situ and in vitro surveys. Stem Cells 2007, 25:319-331.
36. Sarugaser R., Lickorish D., Baksh D., Hosseini M.M., Davies J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005, 23:220-229.
37. Wang H.S., Hung S.C., Peng S.T., et al. Mesenchymal stem cells in the Wharton's jelly of the human cord blood. Stem Cells 2004, 22:1330-1337.
38. Crisan M., Yap S., Castella L., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
39. Sarugaser R., Ennis J., Stanford W.L., Davies J.E. Isolation, propagation, and characterization of human umbilical cord perivascular cells. Methods Mol. Biol. 2009, 482:269-279.
40. Baksh D., Yao R., Tuan R. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
41. Hass R., Kasper C., Bohm S., Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 2011, 9:12.
42. Farraz N., McGuckin C.P. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif. 2011, 44:60-69.
43. Kogler G., Sensken S., Airey J.A., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 2004, 200:123-135.
44. Langenbach F., Berr K., Naujoks C., et al. Generation and differentiation of microtissues from multipotent precursor cells for use in tissue engineering. Nat. Protoc. 2011, 6:1726-1735.
45. Handschel J., Naujoks C., Langenbach F., et al. Comparison of ectopic bone formation of embryonic stem cells and cord blood stem cells in vivo. Tissue Eng. 2010, 16:2475-2483.
46. Zaibak F., Bello P., Zorlovski J., Crombie D., Ang H., Dottori M., Williamson R. Unrestricted somatic stem cells from human umbilical cord blood grown in serum-free medium as spheres. BMC Biotechnol. 2009, 9:101.
47. Santurlidis S., Wernet P., Ghanjati F., et al. Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes. Stem Cell Res. 2011, 6:60-69.
48. + stem cells identified in adult bone marrow. Leukemia 2006, 20:857-869.
49. Ratjczak J., Wysoczynski M., Zuba-Surma E., Wan W., Kucia M., Yoder M.C. Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells. Exp. Hematol. 2011, 39:225-237.
50. Taichman R.S., Wang Z., Shiozawa Y., et al. Prospective identification and skeletal localization of cells capable of multilineage differentiation in vivo. Stem Cells Dev. 2010, 19:1557-1570.
51. + very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 2007, 21:297-303.
52. Zuba-Surma E.K., Klich I., Greco N., Laughlin M.J., Ratajczak J., Ratajczak M.Z. Optimization of isolation and further characterization of umbilical-cord-blood-derived very small embryonic/epiblast-like stem cells. Eur. J. Haematol. 2010, 84:34-46.
53. McGuckin C., Jurga M., Ali H., Strbad M., Forraz N. Culture of embryonic-like stem cells from human cord blood and onward differentiation to neural cells in vitro. Nat. Protoc. 2008, 3:1046-1055.
54. Ratajczak J., Zuba-Sharma E., Klich I., et al. Hematopoietic differentiation of umbilical cord blood-derived very small embryonic/epiblast-like stem cells. Leukemia 2011, 25:1278-1285.
55. Foeken L.M., Green A., Hurley C.K., Marry E., Wiegand T., Ondshoorn M., Conor R. Monitoring the international use of unrelated donors for transplantation: the WMDA reports. Bone Marrow Transplant. 2010, 45:811-818. Registries working group of the World Marrow Donor Association.
56. Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic SCID/SCID mice. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9836-9841.
57. Ueda T., Tsuji K., Yoshino H., et al. Expansion of human NOD/SCID repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6 and soluble IL-6 receptor. J. Clin. Invest. 2000, 105:1013-1021.
58. Dahlberg A., Delaney C., Bernstein I.D. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 2011, 117:6083-6090.
59. Pajcini K.V., Speck N.A., Pear W.S. Notch signaling in mammalian hematopoietic stem cells. Leukemia 2011, 25:1525-1532.
60. Clements W.K., Kim A.D., Ong K.C., Moore J.C., Lawson N.D., Traver D. A somatic Wnt16/notch pathway specifies haematopoietic stem cells. Nature 2011, 2011(474):220-225.
61. Kumano K., Chiba S., Kuisato A., Sato M., Sato T., Nakani-Yamaguchi E. Notch1 but not notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003, 18:699-711.
62. Karanu F.N., Murdoch B., Gallacher L., Wu D.M., Koremoto M., Sakano S. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 2000, 192:1365-1372.
63. Maillard I., Koch U., Dumortier A. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2008, 2:356-366.
64. Dahlberg A., Delaney C., Bernstein I.D. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 2011, 117:6083-6090.
65. - cord blood cells. J. Clin. Invest. 2002, 110:1165-1174.
66. Delaney C., Varnum-Finney B., Aoyama K., Brashem-Stein C., Bernstein I.D. Dose-dependent effects of the notch ligand delta1 on ex vivo differentiation and in vivo repopulating ability of cord blood cells. Blood 2005, 106:2693-2699.
67. Delaney C., Heimfeld S., Brashem-Stein C., Voorhies H., Manger R.L., Bernstein I.D. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 2010, 16:232-237.
68. Dallas M.H., Varnum-Finney B., Delaney C., Kato K., Bernstein I.D. Density of the notch ligand delta1 determines generation of B and T cell precursors from hematopoietic stem cells. J. Exp. Med. 2005, 201:1361-1366.
69. North T.E., Goessling W., Walklery C.R., et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007, 447:1007-1011.
70. Hoggatt J., Singh P., Sampath J., Pelus L.M. Prostaglandin E2 enhances hematopoietic stem cell homing, survival and proliferation. Blood 2009, 113:5444-5454.
71. Goessling W., North T.E., Loewer S., et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009, 2009(136):1136-1147.
72. Frisch B.J., Porter R.L., Gigliotti B.J., et al. In vivo prostaglandin E2 treatment alters the bone marrow microenviroment and preferentially expands shor-term hematopoietic stem cells. Blood 2009, 114:4054-4063.
73. Goessling W., Allen R.S., Guan X., et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 2011, 8:445-458.
74. Zhang C.C., Kaba M., Ge G., Xie K., Tong W. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat. Med. 2006, 12:240-245.
75. Huynh H., Izuka S., Kaba M., Kirak O., Zhenh J. Insulin-like growth factor-binding protein 2 secreted by a tumorigenic cell line supports ex vivo expansion of mouse hematopoietic stem cells. Stem Cells 2008, 26:1628-1635.
76. Zhang C.C., Kaba M., Izuka S., Huynh H., Lodish H.F. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 2008, 111:3415-3423.
77. -/- (NSG) mice. PLoS One 2011, 6:e18832.
78. Khoury M., Drake A., Chen Q., et al. Mesenchymal stem cells secreting engiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential. Stem Cell Dev. 2011, 20:1371-1381.
79. Zheng J., Huynh H., Umikawa M., Silvany R., Zhang C.C. Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Blood 2011, 117:470-479.
80. Boitano A.E., Wang J., Romeo R., et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010, 329:1345-1348.
81. + cells. Br. J. Haematol. 2002, 116:655-661.
82. Peled T., Gluckman E., Hasson N., Adi S., Assor H., Yudin D. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. Exp. Hematol. 2005, 33:1092-1110.
83. Peled T., Mandel J.L., Goudsmid R., Landor C., Hasson N., Harati T. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylene-pentamine. Cytotherapy 2004, 6:344-355.
84. + cells and increases their engraftment potential in NOD/SCID mice. Exp. Hematol. 2004, 32:547-555.
85. De Lima M., McMannis J., Gee A., et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylene-pentamine: a phase I/II clinical trial. Bone Marrow Tranplant. 2008, 41:771-778.
86. De Felice L., Tatarelli C., Mascolo M.G., et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res. 2005, 65:1505-1513.
87. Zardo G., Cimino G., Nervi C. Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming. Leukemia 2008, 22:1503-1518.
88. Milhem M., Mahmud N., Lavelle D. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. Blood 2004, 103:4102-4110.
89. Araki H., Mahmud N., Milhem M. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp. Hematol. 2006, 34:140-149.
90. Araki H., Yoshinaga K., Boccuni P., Zhao Y., Hoffman R., Mahmud N. Chromatin-modifying agents permits human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 2007, 109:3570-3578.
91. Christopherson K.W., Angok G., Mantel C.R., Broxmeyer H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004, 305:1000-1003.
92. - human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/beta2 null immunodeficient mice. Stem Cells Dev. 2007, 16:355-360.
93. Christepherson K.W., Cooper S., Broxmeyer H.E. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood 2003, 101:4680-4686.
94. - mice. Exp. Hematol. 2003, 31:1126-1134.
95. -/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis. Exp. Hematol. 2011, 39:384-390.
96. Gekas C., Dieterlen-Lievre F., Orkin S.H., Mikkola H.K. The placenta is a niche for hematopoietic stem cells. Dev. Cell 2005, 8:365-375.
97. Ottersbasch K., Dzierzak E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev. Cell 2005, 8:377-387.
98. Rhodes K.E., Gekas C., Wang Y., et al. The emergence of the hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell 2008, 2:252-263.
99. Corbel C., Salaun J., Belo-Diabougouaya P., Dieterlen-Lievre F. Hematopoietic potential of the pre-fusion allantois. Dev. Biol. 2007, 301:478-488.
100. Robin C., Bollerot K., Mendes S., et al. Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 2009, 5:385-395.
101. Barcena A., Kapidiric M., Muench M., et al. The human placenta is a hematopoietic organ during the embryonic and fetal periods of development. Dev. Biol. 2009, 327:24-33.
102. Barcena A., Muench M., Kapidiric M., Fisher S.J. A new role for the human placenta as a hematopoietic site throughout gestation. Reprod. Sci. 2009, 6:178-187.
103. Serikov V., Hounshell C., Larkin S., et al. Human term placenta as a source of hematopoietic cells. Exp. Biol. Med. 2009, 234:814-823.
104. Van Handel B., Prashad S., Hassanzadeh-Kiabi N., et al. The first trimester human placenta is a site for terminal maturation of primitive erythroid cells. Blood 2010, 116:3321-3330.
105. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004, 22:649-658.
106. Castrechini N.M., Murthi P., Gude N.M., et al. Mesenchymal stem cells in human placental chorionic villi reside in a vascular niche. Placenta 2010, 31:203-212.
107. Brooke G., Rossetti T., Pelekamos R., et al. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br. J. Haematol. 2008, 144:571-579.
108. Li C.D., Zhang W.Y., Li H.L., Jiang X.X., Zhang Y., Tang P., Mao N. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood transplantation. Cell Res. 2005, 15:539-547.
109. Haase A., Olmer R., Schwanke K., et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 2009, 5:434-441.
110. Giorgetti A., Montserrat N., Aasen T., et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009, 5:353-357.
111. Giorgetti A., Montserrat N., Rodriguez-Pirà I., Azqueta C., Veiga A., Ipsua Belmonte J.C. Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat. Protoc. 2010, 5:811-820.
112. Ye Z., Zhan H., Mali P., et al. Human-induced pluripotent stem cells from cord blood cells of healthy donors and patients with acquired blood disorders. Blood 2009, 114:5473-5480.
113. Broxmeyer H.E., Lee M.R., Hangoc G., et al. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 2011, 117:4773-4777.
114. Ban H., Nishishita N., Fusaki N., et al. Efficient generation of transgene-free human induced pluripotent stem cells (ipSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14234-14239.
115. Hu K., Yu J., Suknuntha K., et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011, 117:e109-e119.
116. Chou B.K., Mali P., Huang X., et al. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expressing signatures. Cell Res. 2011, 21:518-529.
117. Gore A., Li Z., Fung H.L., Young J., et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471:63-67.
118. Broxmeyer H.E. Will iPS cells enhance therapeutic applicability of cord blood cells and banking?. Cell Stem Cell 2010, 6:21-24.